ReviewActa bio-medica : Atenei Parmensis2017
Diagnostic Imaging and workup of Malignant Pleural Mesothelioma.
Review in Acta bio-medica : Atenei Parmensis, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Localised malignant mesothelioma presenting as an esophageal mass: An unusual manifestation.Radiology case reports · 2026Article
- Review
- Malignant Pleural Effusion: Diagnosis and Treatment-Up-to-Date Perspective.Current oncology (Toronto, Ont.) · 2024Review
- Comments and Illustrations of the European Federation of Societies for Ultrasound in Medicine (EFSUMB) Guidelines: Rare Malignant Pulmonal and Pleural Tumors: Primary Pulmonary Sarcoma and Mesothelioma, Imaging Features on Transthoracic Ultrasound.Diagnostics (Basel, Switzerland) · 2024Review
- Malignant pleural mesothelioma: The disdained member of thoracic oncology!World journal of experimental medicine · 2024Article
- Article
- Computed Tomography of Contemporary Occupational Lung Disease: A Pictorial Review.Diagnostics (Basel, Switzerland) · 2024Review
- Comparative Evaluation of Chest Ultrasonography and Computed Tomography as Predictors of Malignant Pleural Effusion: A Prospective Study.Diagnostics (Basel, Switzerland) · 2024Article
- Rare cancer with primary pleural epithelioid hemangioendothelioma diagnosed by thoracoscopic biopsy achieving disease control after 16 months: case report and literature review.Frontiers in pharmacology · 2024Article
- An overview on multimodal imaging for the diagnostic workup of pleural mesothelioma.Japanese journal of radiology · 2024Review
- Review
- Pleural Neoplasms-What Could MRI Change?Cancers · 2023Review
- Feasibility and safety of extended pleurectomy/decortication for malignant pleural mesothelioma. A single group experience.Thoracic cancer · 2022Article
- The Prognostic Value ofJournal of clinical medicine · 2021Review
- Integrating data from multidisciplinary Management of Malignant Pleural Mesothelioma: a cohort study.BMC cancer · 2021Article
- Liquid Biopsies from Pleural Effusions and Plasma from Patients with Malignant Pleural Mesothelioma: A Feasibility Study.Cancers · 2021Article
- Correlation between CT findings and thoracoscopic diagnosis in diffuse pleural disease.Acta bio-medica : Atenei Parmensis · 2020Article
- Review
- Early and delayed phases of contrast-enhanced CT for evaluating patients with malignant pleural effusion. Results of pairwise comparison by multiple observers.The British journal of radiology · 2018Article
- Malignant pleural mesothelioma: main topics of American Society of Clinical Oncology clinical practice guidelines for diagnosis and treatment.Journal of thoracic disease · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Malignant pleural mesothelioma is the most frequent primary neoplasm of the pleura and its incidence is still increasing.This tumor has a strong association with exposure to occupational or environmental asbestos, often after a long latent period of 30-40 years.Plain chest radiography (CXR) is usually the first-line radiologic examination, but the radiographic findings are nonspecific due to its limited contrast resolution and they need to be complemented by other imaging modalities such as computed tomography (CT), magnetic resonance Imaging (MRI), Positron emission tomography-computed tomography (PET-CT) and ultrasound (US).The aim of this paper is to describe the imaging features of this malignancy, underlining the peculiarity of CXR, CT, MRI, PET-CT and US and also focusing on diagnostic workup, based on the literature evidence and according to our experience.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.